The Institute for Pharmacology and Preventive Medicine
The Institute is an experienced partner of universities, non-university institutions, health insurance companies, and pharmaceutical companies in the implementation of scientific projects in the fields of cardiovascular disease and diabetes.
Recent Activity / Publications in press
Seoudy H, von Eberstein M, Frank J, Thomann M, Puehler T, Lutter G, Lutz M, Bramlage P, Frey N, Saad M, Frank D. HFA-PEFF score: Prognosis in patients with preserved ejection fraction after transcatheter aortic valve implantation. ESC Heart Failure 2021.
Seoudy H, Shamekhi J, Voigtländer L, Ludwig S, Frank J, Kujat T, Bramlage P, Al-Kassou B, Sugiura A, Rangrez AY, Schofer N, Puehler T, Lutter G, Seiffert M, Nickenig G, Conradi L, Frey F, Westermann D, Sinning JM, Frank D. C-Reactive Protein/Albumin Ratio in Patients Undergoing Transcatheter Aortic Valve Replacement. Mayo Clinic Proc 2021.
PubMed listed Publications